Odyssey Acquisition S.A.
Notes to the annual accounts for the period ended 31 December 2021
(Expressed in EUR)
1. GENERAL
Odyssey Acquisition S.A. (the “Company” or “Parent”) was incorporated on 1 June 2021 as a public
limited liability company (Société Anonyme or “S.A.”) based on the laws of the Grand Duchy of
Luxembourg (“Luxembourg”) for an unlimited period. The Company is registered with the Luxembourg
Trade and Companies Register (Registre de Commerce et des Sociétés, in abbreviated “RCS”) under
the number B255412. The Company is a listed entity with its 30.000.000 class A shares and
10.000.000 class A warrants traded in Euronext Amsterdam N.V. under the symbol “ODYSY” and
“ODYSW”, respectively, since 2 July 2021. The Company also has 7,500,000 class B shares and
6,600,000 class B warrants issued and outstanding as at December 31, 2021 that are not listed on a
stock exchange.
The registered office of the Company is located at 9, rue de Bitbourg, L-1273 Luxembourg.
The Company’s corporate purpose is the acquisition of a business with principal business operations
in Europe or in another geographic area, that is based in the healthcare sector or the TMT
(technology, media, telecom) sector or any other sectors through a merger, share exchange, asset
acquisition, share repurchase, reorganization or similar transaction (the “Business Combination”).
The Company will not conduct operations or generate operating revenue unless and until the
Company consummates the Business Combination. The Company will have 24 months from 6 July
2021 to complete a Business Combination, subject to a six-month extension period if approved by a
shareholder vote. Otherwise, the Company will be liquidated and distribute substantially all of its
assets to its shareholders (other than the Sponsor).
Upon closing of the Business Combination the above Company’s purpose shall cease to apply and
the Company’s purpose shall be as from such time the holding, management, development and
disposal of participations and any interests, in Luxembourg or abroad, in any companies and/or
enterprises in any form whatsoever. The Company may in particular acquire by subscription,
purchase and exchange or in any other manner any stock, shares and other participation securities,
bonds, debentures, certificates of deposit and other debt instruments and more generally, any
securities and financial instruments issued by any public or private entity. It may participate in the
creation, development, management and control of any company and/or enterprise. It may further
invest in the acquisition and management of a portfolio of patents or other intellectual property rights
of any nature or origin.
The Company may borrow in any form. It may issue notes, bonds and any kind of debt and equity
securities. The Company may lend funds, including without limitation, resulting from any borrowings
of the Company and/or from the issue of any equity or debt securities of any kind, to its subsidiaries,
affiliated companies and/or any other companies or entities it deems fit.
The Company may further guarantee, grant security in favour of or otherwise assist the companies in
which it holds a direct or indirect participation or which form part of the same group of companies as
the Company. The Company may further give guarantees, pledge, transfer or encumber or otherwise
create security over some or all of its assets to guarantee its own obligations and those of any other
company, and generally for its own benefit and that of any other company or person. For the
avoidance of doubt, the Company may not carry out any regulated activities of the financial sector
without having obtained the required authorization.
The Company may use any techniques and instruments to manage its investments efficiently and to
protect itself against credit risks, currency exchange exposure, interest rate risks and other risks.
The Company may, for its own account as well as for the account of third parties, carry out any
commercial, financial or industrial operation (including, without limitation, transactions with respect to
- 19 -